Latest Capital Markets News

Jameson Resources has significantly boosted the economic outlook of its Crown Mountain Hard Coking Coal Project, doubling its pre-tax NPV to US$942 million, while advancing environmental approvals and Indigenous partnerships in British Columbia.

DMC Mining Group reported a modest cash outflow for Q2 2025 while securing a loan facility variation and launching a $6 million capital raising to bolster its funding position.

Opyl Limited has secured three key partnerships validating its AI-driven TrialKey platform, completed a strategic review to boost AI capabilities, and strengthened its balance sheet with a $1.5 million capital raise and Bitcoin investment.

Environmental Clean Technologies Limited has secured crucial regulatory approvals for its Bacchus Marsh fertiliser facility and completed a $275K capital raise, while deferring field trials to better align with cropping cycles. The company is also undergoing significant restructuring to improve capital efficiency and focus on strategic growth.

Memphasys Limited has submitted its Felix™ sperm separation system for CE Mark approval, targeting Europe’s $5 billion IVF market, while expanding direct sales in Japan and validating its RoXsta™ oxidative stress diagnostic platform.

Latrobe Magnesium secures EPA licence extension and prepares to start magnesium oxide production in August, while pursuing a significant legal counterclaim and advancing commercial plant plans.

Syrah Resources has launched a A$70 million equity raising and secured a two-year forbearance on its US Department of Energy loan, bolstering its cash position and operational flexibility amid ongoing challenges.

Transurban Group reveals modest participation in its latest Distribution Reinvestment Plan, with new securities priced at $13.4692 ahead of the August payment date.

Arizona Lithium has secured regulatory approval for Phase 1 production at its Prairie Lithium Project in Saskatchewan and raised $4.25 million through an oversubscribed share purchase plan, marking key milestones toward commercial lithium extraction.

Prescient Therapeutics has secured FDA Fast Track designation for PTX-100 in treating relapsed Cutaneous T-Cell Lymphoma and dosed the first patient in its Phase 2a trial, supported by a recent $6.8 million capital raise.

Scalare Partners has forged a strategic collaboration with Silicon Catalyst, a leading US semiconductor accelerator, while advancing its acquisition of Tank Stream Labs, a premier Australian tech coworking provider. These moves position Scalare at the forefront of deep tech support and infrastructure expansion.

Locksley Resources has advanced its Mojave Project with critical drilling permits secured, a strategic $1.47 million capital raise, and a new U.S. OTCQB listing, setting the stage for maiden drilling campaigns targeting rare earths and antimony.